Fifth Third Bancorp reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 499,144 shares of the healthcare conglomerate’s stock after selling 9,541 shares during the period. Fifth Third Bancorp owned approximately 0.06% of UnitedHealth Group worth $183,226,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the business. BlackRock Inc. grew its stake in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. State Street Corp raised its position in shares of UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after purchasing an additional 301,081 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after buying an additional 616,723 shares during the last quarter. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock worth $4,436,923,000 after buying an additional 583,536 shares in the last quarter. Finally, Corient Private Wealth LP increased its stake in shares of UnitedHealth Group by 1,443.7% in the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after buying an additional 7,900,011 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
Shares of UNH opened at $403.14 on Thursday. The stock has a market capitalization of $361.22 billion, a PE ratio of 19.85, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. The business’s fifty day moving average price is $391.12 and its 200 day moving average price is $364.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio is 53.00%.
Analyst Ratings Changes
UNH has been the topic of several recent analyst reports. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a report on Tuesday, July 21st. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a report on Tuesday, October 27th. Mizuho upped their target price on shares of UnitedHealth Group from $493.00 to $500.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Stephens set a $500.00 price target on shares of UnitedHealth Group in a research report on Friday, October 16th. Finally, Wells Fargo & Company decreased their price target on UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating for the company in a research note on Tuesday, October 27th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $463.93.
Check Out Our Latest Analysis on UnitedHealth Group
Insiders Place Their Bets
In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
